Intellipharmaceutics International Inc. (IPCIF) Stock Price & Growth Analysis - Tweevest

New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out

Quote Panel

Updated October 23, 2025

1W % 1M % 3M % 1Y 0.00 %

Key Metrics

Market Cap
4.96M
Shares Outstanding
33.09M
Share in Float
32.51M
Dividende
0

Earning Date
No Data
Price Target
0.15
Average Volume
Beta
0.397

Range
Industry
Biotechnology
Website
https://www.intellipharmaceutics.com
Sector
Healthcare

Fundamentals

Relative Strength

IPCIF

Sector

loading...

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

N/A

N/A

2025-Revenue

N/A

N/A

2025-EPS

N/A

N/A

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Price Target

N/A(N/A)

Number of analyst

N/A

Last analyst upgrade/downgrade

No Data Available

Earnings Growth

YoY

Current

Estimates

Q2.21

N/A

-0.04
vs -0.04

Q3.21

N/A

-0.04
vs 0.04

Q4.21

N/A

-0.08
vs -0.06

Q1.22

N/A

-0.03
vs -0.04

Q2.22

N/A

-0.05
vs -0.04

Q3.22

N/A

-0.01
vs -0.04

Q4.22

N/A

-0.03
vs -0.08

Q1.23

N/A

-0.01
vs -0.03

Q2.23

N/A

-0.00
vs -0.05

Q3.23

N/A

-0.06
vs -0.01

Sales Growth

YoY

Current

Estimates

Q2.21

-76%

93.4K vs 395.7K

Q3.21

-100%

NA vs 328.8K

Q4.21

-100%

NA vs 299.4K

Q1.22

NA

83.4K vs NA

Q2.22

-11%

83.4K vs 93.4K

Q3.22

NA

19.1K vs NA

Q4.22

NA

29.7K vs NA

Q1.23

+291%

326.3K vs 83.4K

Q2.23

+476%

480.2K vs 83.4K

Q3.23

+260%

68.7K vs 19.1K

Return on Equity

QoQ

Q2.21

+20%

0.2
vs 0.13

Q3.21

+20%

0.2
vs 0.2

Q4.21

+30%

0.3
vs 0.2

Q1.22

+9%

0.09
vs 0.3

Q2.22

+10%

0.1
vs 0.09

Q3.22

+3%

0.03
vs 0.1

Q4.22

+8%

0.08
vs 0.03

Q1.23

+3%

0.03
vs 0.08

Q2.23

+0%

0
vs 0.03

Q3.23

+15%

0.15
vs 0

Institutionnal Ownership

QoQ

Q3.16

NA

NA
vs NA

NA

Q4.16

NA

NA
vs NA

NA

Q1.17

NA

NA
vs NA

NA

Q2.17

NA

NA
vs NA

NA

Q3.17

NA

NA
vs NA

NA

Q4.17

NA

NA
vs NA

NA

Q1.18

NA

NA
vs NA

NA

Q2.18

NA

NA
vs NA

NA

Q3.18

7

7
vs NA

NA

Q4.18

5

5
vs 7

-29%

Earnings Growth

Latest News

IPCIF

accesswire.com

14 hours ago

Intellipharmaceutics Announces Cease Trade Order

IPCIF

accesswire.com

16 hours ago

Intellipharmaceutics Announces Downgrade to OTC Expert Market

IPCIF

accesswire.com

16 hours ago

Intellipharmaceutics International Inc. Announces Stock Option Grant

IPCIF

accesswire.com

17 hours ago

Intellipharmaceutics International Inc. Announces Transfer of Listing to NEX and New Stock Option Plan

IPCIF

accesswire.com

17 hours ago

Intellipharmaceutics International Inc. Receives Conditional Approval to List on the TSX Venture Exchange

IPCIF

accesswire.com

19 hours ago

Intellipharmaceutics Announces Its Expected Delay in Filing Annual Audited Financial Statements and Annual Information Form